Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. D. G. van de Kant, J. van Berkel, J. C. De Jongste, Q. Jobsis, C. M. H. H. T. Robroeks, J. Dallinga, C. P. van Schayck, F. J. van Schooten, E. Dompeling (Maastricht, Rotterdam, Netherlands). Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze. Eur Respir J 2009; 34: Suppl. 53, 1193

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled breath profiling in diagnosing wheezy preschool children Source: Eur Respir J 2013; 41: 183-188 Year: 2013 Inflammatory markers in exhaled breath condensate differ between pre-school children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Measurement of volatile organic compounds in exhaled breath of children of the ALL Age Asthma Cohort Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018 Exhaled volatile organic compounds differentiate between children with atopic asthma and healthy controls Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Exhaled breath VOCs are associated with nocturnal wakening in asthmatic children Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Real-time analysis of exhaled volatile organic compounds (eVOC) in wheezy preschool children Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020 Leukotrienes in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003 Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018 Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Pattern of exhaled volatile organic compounds is altered in children with obstructive sleep apnea Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 8-isoprostane in exhaled breath condensate (EBC) and air pollution exposure in children with wheezing Source: Annual Congress 2012 - Indoor and outdoor air pollution Year: 2012 Profile of prostanoids in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003 Nitrite levels in breath condensate of children with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001